Insmed Incorporated
Biopharmaceutical company comments on recent actions by Tercica, Inc.
Published in Law and Health Weekly, February 5th, 2005
On December 23, 2004, Tercica Inc. and its licensor, Genentech, filed a lawsuit in the U.S. District Court for Northern California against Insmed challenging Insmed's right to commercialize its proprietary IGF-I replacement hormone, SomatoKine, in the United States and seeking damages for alleged patent infringement by Insmed's predecessor, Celtrix, of certain patents licensed to Tercica.
Tercica also filed a lawsuit in the United Kingdom against Insmed and its contract manufacturer, Avecia, that was announced last week.
In response to these events, Insmed's chief...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Correctional Health
Jury awards $1.2 million to two men sickened in jail infection - Dana Farber Cancer Institute
Outer domain of the gp120 glycoprotein from HIV-1 characterized - Grant Life Sciences
Notice of Allowance issued for blood test that detects HPV-associated cancers - Information Technology
DecisionPath inks contract with U.S. Social Security Administration - Legal Issues
Wyoming advocacy group sues state over treatment of mentally ill patients - Medical Ethics
U.S. researchers ordered not to put royalties on ethics reports - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
